Abstract:Parkinson’s Disease (PD) is a prevalent and devastating neurodegenerative disorder that causes progressively worsening motor symptoms affecting locomotor and oropharyngeal function. There is limited research in animal models on swallowing dysfunction in PD. To examine how neurodegeneration in PD produces progressive impairment in the oropharyngeal and locomotor processes, rotenone, a type II mitochondrial inhibitor, was injected into Lewis rat models to reproduce a parkinsonian phenotype. We hypothesized that the animal models injected with the rotenone will exhibit both oropharyngeal dysfunction and locomotor deficiency with an increased deficit that correlates with prolonged treatment. We utilized 18 rats receiving either 2.75 mg/kg of rotenone or vehicle intraperitoneal injections. Animals received daily injections for 17 or 8 days. At the end of the injections in each group brains were perfused and immunostained for striatal tyrosine hydroxylase (TH). High speed (200 fps) videofluoroscopic recording was taken of these rats and average chew cycle length, chewing rate, and total chewing time data were collected from days 0, 1, 4, 7 and 16 of those recordings. The number of rears by a rat in a glass cylinder over 4 minutes was counted on the same days to assess locomotor behavior. We used mixed model ANOVA, controlling for the effect of individual variation, to test the impact of rotenone treatment on feeding and locomotor variables. We used a Kruskall-Wallis non parametric test to test the effect of rotenone treatment on striatal TH levels. Total chewing time, and average chew cycle duration increased in rotenone treated rats from day 0 to day 4, but the difference disappeared from day 7 onwards. However, rearing behavior was consistently reduced in rotenone treated rats for all 16 days. TH staining intensity in the striatum decreased consistently over the course of the injections. These results suggest that rotenone treated rats have temporary/short term deficiency in chewing function, despite sustained reduction in spontaneous locomotor activity. The restoration of function after day 4 may indicate a learned behavior to compensate for this dysfunction in chewing, or point to a different neurological impairment than that seen in locomotor behavior. Further research needs to be undertaken to understand this phenomenon. Internal Rowan funding to F. Gould supported this work. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Behavior alteration and damage of dopaminergic neurons of substantia nigra caused by rotenone in rats

Subcutaneous Rotenone Rat Model of Parkinson's Disease: Dose Exploration Study.

Identification of Novel Proteins Affected by Rotenone in Mitochondria of Dopaminergic Cells

Neurotoxic effect of rotenone on dopaminergic neuron

Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice

Effects of Different Doses of L -Dopa on Rotational Behavior and Amounts of Cells Expressing D2 Receptors in Hemiparkinsonian Rats

Selective protection of nigral dopaminergic neurons by echinacoside in a rat model of Parkinson disease induced by rotenone.

Mechanisms of rotenone-induced neurotoxicity in PC 12 cells

Rotenone Induces Hepatotoxicity in Rats by Activating the Mitochondrial Pathway of Apoptosis

Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons

Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson's rats

Protective effect of sterubin against neurochemical and behavioral impairments in rotenone-induced Parkinson's disease

Loss of substantia nigra neurons in Parkinson disease rats

Protective effect of metformin against rotenone-induced parkinsonism in mice

Ultrastructural Changes of Neuroendocrine Pheochromocytoma Cell Line PC-12 Exposed In Vitro to Rotenone

Neuroprotective effect of quercetin against rotenone-induced neuroinflammation and alterations in mice behavior

Rotenone, an environmental toxin, causes abnormal methylation of the mouse brain organoid's genome and ferroptosis

Effect of dosage duration on oropharyngeal and locomotor in a toxicological rat model of Parkinson’s disease

Rotenone-Induced Optic Nerve Damage and Retinal Ganglion Cell Loss in Rats

[Protective Effect of Exogenous Superoxide Dismutase Against Rat Midbrain Dopaminergic Neuron Apoptosis Induced by 6-Hydroxydopamine].

Rotenone Could Activate Microglia Through NFκB Associated Pathway